STANDARD BIOTOOLS INC.

LAB

STANDARD BIOTOOLS INC.

LAB

Insider Sentiment (TTM):

Last Purchase:2025-12-03Last Sale:2025-05-23Shares Purchased (TTM):9,150,000Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:296,246,988Shares Outstanding:388,202,000Institutional Ownership Pct.:76.31%

Earnings Market Reaction:

Filing Date:2026-08-05Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	270	266	121	129	159	151	167	211	270	287	52	80
Available For Sale Securities Debt Securities Curr…	207	189	67	65	78	107	126	156	125	175	63	49
Accounts Receivable Net Current	16	17	13	14	15	35	15	35	32	36	20	17
Inventory Net	17	19	20	25	24	42	21	43	43	40	21	22
Prepaid Expense And Other Assets Current	7	6	5	8	7	8	5	9	10	9	3	3
Assets Of Disposal Group Including Discontinued Op…	0	0	228	231	223	-	43	-	-	-	-	-
Assets Current	517	521	454	472	506	344	376	454	480	548	158	171
Inventory Noncurrent	-	-	-	-	-	18	19	18	16	13	0	-
Property Plant And Equipment Net	15	17	19	21	23	44	23	42	43	45	24	25
Operating Lease Right Of Use Asset	24	26	27	23	25	27	27	30	32	33	31	31
Other Assets Noncurrent	3	3	3	4	4	7	4	5	4	4	2	2
Intangible Assets Net Excluding Goodwill	-	-	-	-	-	28	29	23	24	25	1	4
Goodwill	-	-	-	-	-	112	111	106	106	106	106	106
Long Term Investments	67	71	26	19	-	-	0	-	-	-	-	-
Deferred Income Tax Assets Net	0	0	39	-	-	-	0	-	-	-	-	-
Disposal Group Including Discontinued Operation As…	-	-	0	0	0	-	183	-	-	-	-	-
Assets	627	639	568	540	557	580	612	682	709	778	323	339
Liabilities And Stockhold…
Liabilities Current
Employee Related Liabilities Current	-	-	-	-	-	-	-	-	-	-	12	10
Accounts Payable Current	10	8	5	7	7	12	5	11	13	13	9	7
Accrued Liabilities Current	30	16	30	31	24	22	21	32	32	30	21	10
Operating Lease Liability Current	6	6	5	5	5	6	5	6	6	6	4	4
Contract With Customer Liability Current	9	10	39	40	40	13	10	13	15	14	12	11
Secured Debt Current	-	-	-	-	-	-	0	0	0	0	5	5
Liabilities Of Disposal Group Including Discontinu…	0	0	26	22	18	-	21	-	-	-	-	-
Convertible Debt Current	-	-	-	-	-	-	0	55	55	55	55	-
Liabilities Current	57	42	108	108	98	56	66	121	124	122	109	52
Convertible Long Term Notes Payable	-	-	-	-	-	-	-	-	-	-	-	55
Convertible Debt Noncurrent	0	0	0	0	0	0	0	0	0	0	1	-
Deferred Income Tax Liabilities Net	1	1	1	1	1	1	1	1	1	1	1	1
Secured Long Term Debt	-	-	-	-	-	-	0	0	0	0	3	5
Operating Lease Liability Noncurrent	22	24	25	22	23	25	26	28	30	31	30	31
Contract With Customer Liability Noncurrent	3	3	4	2	3	33	33	33	33	34	4	3
Other Liabilities Noncurrent	1	4	1	1	1	3	1	2	2	3	1	1
Disposal Group Including Discontinued Operation Ot…	-	-	-	0	0	-	7	-	-	-	-	-
Liabilities	87	78	143	140	132	125	141	192	198	200	160	160
Temporary Equity
Stockholders Equity
Temporary Equity Carrying Amount Attributable To P…	-	-	-	-	-	-	0	0	0	0	311	311
Preferred Stock Value	-	-	-	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	1,745	1,741	1,732	1,726	1,718	1,711	1,702	1,688	1,682	1,675	861	857
Accumulated Other Comprehensive Income Loss Net Of…	1	-1	-1	-0	-2	1	1	-1	-2	-2	-2	-2
Retained Earnings Accumulated Deficit	-1,160	-1,133	-1,261	-1,280	-1,245	-1,212	-1,186	-1,152	-1,125	-1,079	-1,001	-981
Treasury Stock Common Value	-46	-46	-46	-46	-46	-46	-46	-46	-46	-17	-6	-6
Stockholders Equity	540	561	424	400	425	455	472	489	510	577	-148	-132
Liabilities And Stockholders Equity	627	639	568	540	557	580	612	682	709	778	323	339
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Temporary Equity Par Or Stated Value Per Share	-	-	-	-	-	-	0.001	0.001	0.001	0.001	0.001	0.001
Allowance For Doubtful Accounts Receivable Current	-	-	-	-	-	-	-	-	-	-	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Temporary Equity Shares Authorized	-	-	-	-	-	-	0	0	0	0	0	0
Temporary Equity Shares Issued	-	-	-	-	-	-	0	0	0	-	0	0
Common Stock Shares Authorized	600	600	600	600	600	600	600	600	600	600	400	400
Common Stock Shares Issued	411	409	405	402	400	398	396	391	390	388	83	83
Temporary Equity Shares Outstanding	-	-	-	-	-	-	0	0	0	-	0	0
Shares Outstanding	392	390	386	384	382	379	378	372	371	380	80	79
Temporary Equity Liquidation Preference	-	-	-	-	-	-	0	0	0	0	256	256
Treasury Stock Common Shares	19	19	19	19	19	19	19	19	19	7	3	3

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	18.56%	-24.74%	-14.43%	-	-	-	-	-	-	-	-	-
2025	-4.72%	12.26%	32.08%	5.69%	8.94%	-2.44%	26.05%	15.97%	30.25%	-7.29%	6.25%	19.79%
2024	2.90%	-26.56%	-2.49%	39.22%	25.49%	9.80%	-18.58%	-19.47%	-26.99%	-6.14%	5.26%	-11.40%
2023	-	-	-	28.15%	21.85%	-23.53%	30.65%	11.06%	19.10%	7.20%	0.80%	2.80%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	9.10	12.36	4.19	4.38	5.16	6.12	5.70	3.76	3.88	4.50	1.45	3.30
Quick Ratio	8.67	11.77	3.96	4.07	4.84	5.22	5.32	3.33	3.45	4.10	1.23	2.81
Working Capital	460.07M	479.25M	345.96M	364.47M	408.01M	287.78M	309.99M	332.99M	356.22M	426.01M	48.89M	118.94M
Leverage & Debt
Debt to Equity	0.16	0.14	0.34	0.35	0.31	0.27	0.30	0.39	0.39	0.35	-1.08	-1.21
Interest Coverage TTM	-	-	-	-	-	-	-	-126.16	-57.30	-34.84	-16.77	-16.38
Debt Ratio	0.14	0.12	0.25	0.26	0.24	0.22	0.23	0.28	0.28	0.26	0.49	0.47
Efficiency & Turnover
Asset Turnover TTM	0.14	0.14	0.14	0.10	0.10	0.10	0.19	0.23	0.23	0.22	0.30	0.28
Days Sales Outstanding TTM	65.49	110.27	60.25	142.82	132.19	198.62	68.98	80.03	71.39	72.73	63.40	58.74
Receivables Turnover TTM	5.57	3.31	6.06	2.56	2.76	1.84	5.29	4.56	5.11	5.02	5.76	6.21
Per Share Metrics
Diluted EPS TTM	0.22	0.20	-0.20	-0.34	-0.32	-0.35	-0.52	-0.46	-0.44	-0.46	-0.94	-0.96
Free Cash Flow Per Share TTM	-0.21	-0.24	-0.22	-0.26	-0.28	-0.33	-0.43	-0.40	-0.35	-0.34	-0.58	-0.66
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	50.49%	49.62%	49.86%	47.03%	49.26%	48.32%	49.32%	50.80%	48.63%	49.19%	47.44%	57.47%
Operating Profit Margin TTM	-112.85%	-111.04%	-129.20%	-153.70%	-138.10%	-143.51%	-140.08%	-117.09%	-109.39%	-94.82%	-72.03%	-72.57%
Net Profit Margin TTM	100.37%	90.67%	-87.77%	-205.44%	-185.50%	-202.10%	-203.17%	-144.20%	-135.43%	-107.28%	-70.21%	-72.00%
Growth Metrics
Net Revenue Growth (1Y)	30.23%	31.31%	-6.24%	-47.23%	-46.57%	-48.18%	-14.42%	12.49%	15.30%	31.27%	8.57%	-3.68%
Net Income Growth (1Y)	-170.46%	-158.91%	-59.49%	-24.82%	-26.82%	-2.37%	147.67%	125.29%	95.67%	4.08%	-60.73%	-57.62%
EPS Growth (1Y)	-168.59%	-157.39%	-62.51%	-27.00%	-28.39%	-24.08%	-44.50%	-52.00%	-58.66%	-72.02%	-61.15%	-57.76%
Valuation Metrics
P/E TTM	3.78	4.57	-6.52	-3.88	-3.79	-3.08	-3.34	-4.20	-4.00	-5.86	-2.34	-3.03
P/B TTM	0.59	0.64	1.15	1.24	1.08	0.90	1.31	1.47	1.29	1.38	-1.18	-1.74
P/S TTM	3.79	4.14	5.72	7.97	7.03	6.22	6.79	6.06	5.42	6.29	1.65	2.18
Market Cap	320.52M	357.15M	488.48M	497.42M	456.60M	408.49M	618.18M	717.07M	659.03M	797.08M	174.94M	229.54M
Enterprise Value	48.70M	89.58M	365.48M	365.71M	295.69M	255.31M	449.66M	560.34M	443.01M	563.69M	185.96M	213.68M
Calculated Values
Free Cash Flow TTM	-82.58M	-94.48M	-82.65M	-98.42M	-105.46M	-123.89M	-151.81M	-148.51M	-130.70M	-99.88M	-46.12M	-51.92M
Net Debt	-271.82M	-267.57M	-123.00M	-131.71M	-160.91M	-153.17M	-168.52M	-156.73M	-216.02M	-233.39M	11.01M	-15.86M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-12-03Purchase

Owner: Casdin, Private Growth Eq…

Title: -

Shares: 75,000

Price/Share: $1.44

Value: $108,000.00

Shares Owned: 71,950,000

Relationship: Director

Ownership: Indirect

2025-11-25Purchase

Owner: Casdin, Partners Gp, Llc,…

Title: -

Shares: 7,550,000

Price/Share: $1.30

Value: $9,815,000.00

Shares Owned: 71,750,000

Relationship: Director,TenPercentOwner

Ownership: Indirect

2025-11-20Purchase

Owner: Casdin, Eli, Casdin Priva…

Title: -

Shares: 450,000

Price/Share: $1.30

Value: $585,000.00

Shares Owned: 64,050,000

Relationship: Director,TenPercentOwner

Ownership: Indirect

2025-11-17Purchase

Owner: Casdin, Partners Master F…

Title: -

Shares: 225,000

Price/Share: $1.22

Value: $274,500.00

Shares Owned: 62,975,000

Relationship: Director

Ownership: Indirect

2025-11-12Purchase

Owner: Casdin, Partners Gp, Llc,…

Title: -

Shares: 375,000

Price/Share: $1.19

Value: $446,250.00

Shares Owned: 62,050,000

Relationship: Director,TenPercentOwner

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-12-03	Casdin, Private Growth Eq…	Director	-	Indirect	Purchase	75,000	1.44	$108,000.00	71,950,000	4
2025-11-25	Casdin, Partners Gp, Llc,…	Director,TenPercentOwner	-	Indirect	Purchase	7,550,000	1.30	$9,815,000.00	71,750,000	4
2025-11-20	Casdin, Eli, Casdin Priva…	Director,TenPercentOwner	-	Indirect	Purchase	450,000	1.30	$585,000.00	64,050,000	4
2025-11-17	Casdin, Partners Master F…	Director	-	Indirect	Purchase	225,000	1.22	$274,500.00	62,975,000	4
2025-11-12	Casdin, Partners Gp, Llc,…	Director,TenPercentOwner	-	Indirect	Purchase	375,000	1.19	$446,250.00	62,050,000	4
2025-09-09	Casdin, Partners Master F…	Director,TenPercentOwner	-	Indirect	Purchase	100,000	1.29	$129,000.00	60,875,000	4
2025-09-04	Casdin, Eli, Casdin Partn…	Director,TenPercentOwner	-	Indirect	Purchase	250,000	1.28	$320,000.00	60,775,000	4
2025-08-26	Casdin, Partners Master F…	Director	-	Indirect	Purchase	125,000	1.26	$157,500.00	60,275,000	4
2025-08-15	Casdin, Eli, Casdin Priva…	Director	-	Indirect	Purchase	150,000	1.22	$183,000.00	59,750,000	4
2025-05-23	Mackay, Sean	Officer	SVP & Chief Business Officer	Direct	Sale	13,217	0.94	$12,423.98	843,076	4
2025-05-23	Egholm, Michael	Director,Officer	President & CEO	Direct	Sale	5,473	0.94	$5,144.62	2,741,191	4
2025-05-23	Kim, Hanjoon Alex	Officer	Chief Financial Officer	Direct	Sale	1,428	0.94	$1,342.32	930,286	4
2025-05-22	Kim, Hanjoon Alex	Officer	Chief Financial Officer	Direct	Sale	1,355	1.00	$1,355.00	931,714	4
2025-05-22	Mackay, Sean	Officer	SVP & Chief Business Officer	Direct	Sale	12,536	1.00	$12,536.00	856,293	4
2025-05-22	Egholm, Michael	Director,Officer	President & CEO	Direct	Sale	5,116	1.00	$5,116.00	2,746,664	4
2025-05-21	Egholm, Michael	Director,Officer	President & CEO	Direct	Sale	4,719	1.03	$4,860.57	2,751,780	4
2025-05-21	Kim, Hanjoon Alex	Officer	Chief Financial Officer	Direct	Sale	1,407	1.03	$1,449.21	933,069	4
2025-02-28	Casdin, Capital, Llc, Cas…	Director,TenPercentOwner	-	Indirect	Purchase	4,820,959	1.07	$5,158,426.13	58,846,780	4
2024-08-27	Casdin, Private Growth Eq…	Director	-	Indirect	Purchase	250,000	2.19	$547,500.00	54,025,821	4
2024-08-26	Casdin, Private Growth Eq…	Director	-	Indirect	Purchase	150,000	2.15	$322,500.00	53,775,821	4
2024-08-21	Casdin, Amplify Fund, Lp,…	Director,TenPercentOwner	-	Indirect	Purchase	500,000	1.90	$950,000.00	53,025,821	4
2024-08-14	Casdin, Private Growth Eq…	Director	-	Indirect	Purchase	1,200,000	1.59	$1,908,000.00	51,775,821	4
2024-08-13	Casdin, Amplify Fund, Lp,…	Director,TenPercentOwner	-	Indirect	Purchase	550,000	1.62	$891,000.00	50,575,821	4
2024-08-08	Casdin, Private Growth Eq…	Director,TenPercentOwner	-	Indirect	Purchase	569,562	1.64	$934,081.68	49,000,413	4
2024-08-05	Casdin, Eli, Casdin Priva…	Director	-	Indirect	Purchase	200,000	1.58	$316,000.00	47,930,821	4
2024-05-23	Casdin, Partners Fo1-Msv,…	Director,TenPercentOwner	-	Indirect	Purchase	100,000	2.60	$260,000.00	46,075,821	4
2024-05-22	Casdin, Partners Gp, Llc,…	Director	-	Indirect	Purchase	150,000	2.58	$387,000.00	45,975,821	4
2024-05-17	Casdin, Eli, Casdin Priva…	Director,TenPercentOwner	-	Indirect	Purchase	352,072	2.56	$901,304.32	45,375,821	4
2024-03-05	Casdin, Private Growth Eq…	Director,TenPercentOwner	-	Direct	Purchase	1,403	2.62	$3,675.86	11,497,928	4
2023-05-19	Casdin, Private Growth Eq…	Director	-	Indirect	Purchase	800,000	2.29	$1,832,000.00	1,200,000	4
2023-05-19	Black, Jeffrey G.	Officer	SVP & Chief Financial Officer	Direct	Purchase	42,492	2.29	$97,306.68	85,984	4
2023-05-19	Casdin, Eli	Director,TenPercentOwner	-	Indirect	Purchase	800,000	2.29	$1,832,000.00	1,200,000	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

76.31%

Inst. Shares: 296,246,988

Shares Outstanding: 388,202,000

2025-12-31

79.12%

Inst. Shares: 301,949,236

Shares Outstanding: 381,623,000

2025-09-30

74.55%

Inst. Shares: 285,252,817

Shares Outstanding: 382,630,000

2025-06-30

72.66%

Inst. Shares: 276,464,053

Shares Outstanding: 380,498,000

2025-03-31

73.34%

Inst. Shares: 277,398,249

Shares Outstanding: 378,228,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	296,246,988	388,202,000	76.31%
2025-12-31	301,949,236	381,623,000	79.12%
2025-09-30	285,252,817	382,630,000	74.55%
2025-06-30	276,464,053	380,498,000	72.66%
2025-03-31	277,398,249	378,228,000	73.34%
2024-12-31	273,378,578	353,245,000	77.39%
2024-09-30	276,437,057	371,538,000	74.40%
2024-06-30	267,072,075	372,331,000	71.73%
2024-03-31	258,924,123	294,125,000	88.03%
2023-12-31	47,193,145	79,160,000	59.62%
2023-09-30	46,655,026	79,152,000	58.94%
2023-06-30	45,333,288	78,669,000	57.63%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

STANDARD BIOTOOLS INC. (LAB) — SEC Financial Statements & Analysis

STANDARD BIOTOOLS INC. (LAB) is a pharmaceutical preparations company, incorporated in DE. STANDARD BIOTOOLS INC. trades on Nasdaq as: LAB. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), STANDARD BIOTOOLS INC. reported a 30.23% year-over-year revenue growth, a Gross Profit Margin of 50.49% (TTM), a Debt-to-Equity ratio of 0.16x, a Price-to-Sales (P/S) ratio of 3.79x (TTM), a Price-to-Book (P/B) ratio of 0.59x (TTM), at a market cap of $320.52M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 30.23%
Gross Profit Margin TTM: 50.49%
Debt To Equity: 0.16x
P/S TTM: 3.79x
P/B TTM: 0.59x
Market Cap: $320.52M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is STANDARD BIOTOOLS INC. in?

STANDARD BIOTOOLS INC. (LAB) operates in the Pharmaceutical Preparations industry.

What is LAB's market cap?

STANDARD BIOTOOLS INC. (LAB) has a market capitalization of $320.52M as of 2026-06-30.

What is LAB's P/E ratio?

STANDARD BIOTOOLS INC. (LAB)'s trailing twelve month P/E ratio is 3.78x as of 2026-06-30.

What exchange does LAB trade on?

STANDARD BIOTOOLS INC. (LAB) trades on the Nasdaq.

Where is STANDARD BIOTOOLS INC. incorporated?

STANDARD BIOTOOLS INC. is incorporated in DE.